The effect of high mobility group box-1 protein on immune function of human T lymphocytes in vitro

Li-feng Huang1, Yong-ming Yao, Hai-dong Meng

  • 1Department of Microbiology and Immunology, Burns Institute, First Hospital Affiliated to the Chinese PLA General Hospital, Beijing 100037, China. c_ff@sina.com

Insights

High mobility group box-1 protein (HMGB1) exhibits a dual effect on human T lymphocyte immune function. While low concentrations are tolerated, higher HMGB1 levels can impair T cell proliferation and alter T helper cell balance.

Area of Science:

  • Immunology
  • Molecular Biology

Background:

  • High mobility group box-1 protein (HMGB1) is a nuclear protein with extracellular functions.
  • HMGB1's role in modulating immune responses, particularly T lymphocyte function, requires further elucidation.

Purpose of the Study:

  • To investigate the impact of HMGB1 on human T lymphocyte immune function in vitro.
  • To explore HMGB1's potential role in cell-mediated immune dysfunction.

Main Methods:

  • Peripheral blood mononuclear cells (PBMCs) from healthy volunteers were stimulated with recombinant human HMGB1 (rhHMGB1).
  • Cell viability was assessed using MTT assay.
  • Flow cytometry (FCM) measured CD3, CD8, and CD4 expression.
  • RT-PCR detected gene expression of interleukin-2 (IL-2) and IL-2 receptor alpha (IL-2Rα).

Main Results:

  • rhHMGB1 at 500-1000 microg/L for 48 hours decreased T cell viability.
  • HMGB1 induced a dose- and time-dependent increase in Th2 subset and decreased the Th1/Th2 ratio.
  • Short-term (12 hours) low-dose (10 microg/L) HMGB1 upregulated IL-2 and IL-2Rα mRNA, while long-term (48 hours) high-dose exposure downregulated these genes.

Conclusions:

  • HMGB1 exerts a dual influence on T lymphocyte immune functions.
  • HMGB1 can modulate T cell proliferation, differentiation, and cytokine gene expression.
Abstract